Revolution Medicines (RVMD) Competitors $37.22 -0.31 (-0.83%) Closing price 04:00 PM EasternExtended Trading$37.17 -0.05 (-0.12%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RVMD vs. ONC, BNTX, INSM, SMMT, TEVA, ITCI, GMAB, MRNA, RDY, and VTRSShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include BeOne Medicines (ONC), BioNTech (BNTX), Insmed (INSM), Summit Therapeutics (SMMT), Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Moderna (MRNA), Dr. Reddy's Laboratories (RDY), and Viatris (VTRS). These companies are all part of the "pharmaceutical products" industry. Revolution Medicines vs. Its Competitors BeOne Medicines BioNTech Insmed Summit Therapeutics Teva Pharmaceutical Industries Intra-Cellular Therapies Genmab A/S Moderna Dr. Reddy's Laboratories Viatris BeOne Medicines (NASDAQ:ONC) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment. Do insiders & institutionals believe in ONC or RVMD? 48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are owned by institutional investors. 6.6% of BeOne Medicines shares are owned by insiders. Comparatively, 8.2% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, ONC or RVMD? BeOne Medicines has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Do analysts recommend ONC or RVMD? BeOne Medicines presently has a consensus price target of $327.56, indicating a potential upside of 10.49%. Revolution Medicines has a consensus price target of $68.91, indicating a potential upside of 85.14%. Given Revolution Medicines' higher possible upside, analysts clearly believe Revolution Medicines is more favorable than BeOne Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ONC or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to BeOne Medicines' net margin of -9.40%. BeOne Medicines' return on equity of -7.55% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-9.40% -7.55% -4.42% Revolution Medicines N/A -37.06%-32.84% Which has better earnings and valuation, ONC or RVMD? Revolution Medicines has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$3.81B8.53-$644.79M-$3.72-79.69Revolution Medicines$11.58M598.70-$600.09M-$4.00-9.31 Does the media prefer ONC or RVMD? In the previous week, BeOne Medicines had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 7 mentions for BeOne Medicines and 6 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.21 beat BeOne Medicines' score of 0.54 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRevolution Medicines beats BeOne Medicines on 10 of the 15 factors compared between the two stocks. Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMD vs. The Competition Export to ExcelMetricRevolution MedicinesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.93B$3.05B$5.67B$9.49BDividend YieldN/A2.44%4.05%4.00%P/E Ratio-9.3120.8627.9419.96Price / Sales598.70246.07396.5882.69Price / CashN/A41.9636.1958.45Price / Book2.768.308.635.82Net Income-$600.09M-$55.19M$3.24B$258.42M7 Day Performance-4.69%5.06%3.22%1.94%1 Month Performance-7.02%17.59%10.71%12.02%1 Year Performance-19.96%7.02%34.94%20.81% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDRevolution Medicines4.5827 of 5 stars$37.22-0.8%$68.91+85.1%-19.8%$6.93B$11.58M-9.31250Positive NewsONCBeOne Medicines1.4884 of 5 stars$252.14+0.7%$320.67+27.2%N/A$27.63B$3.81B-67.7811,000Insider TradeBNTXBioNTech1.4405 of 5 stars$111.00-1.7%$137.91+24.2%+34.0%$26.68B$2.98B-32.656,772INSMInsmed4.0636 of 5 stars$101.89+3.8%$108.07+6.1%+36.1%$19.33B$381.03M-17.121,271Positive NewsAnalyst ForecastInsider TradeSMMTSummit Therapeutics3.2103 of 5 stars$25.40+1.6%$34.67+36.5%+177.6%$18.86BN/A-74.70110TEVATeva Pharmaceutical Industries4.1117 of 5 stars$16.43+0.2%$24.71+50.5%-2.2%$18.84B$16.54B-14.2836,830Upcoming EarningsITCIIntra-Cellular Therapies0.9869 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S4.0449 of 5 stars$21.46+0.3%$37.80+76.1%-18.1%$13.77B$3.12B12.192,682MRNAModerna4.2551 of 5 stars$32.87-2.3%$46.61+41.8%-71.4%$12.71B$3.24B-3.775,800Analyst ForecastRDYDr. Reddy's Laboratories2.8143 of 5 stars$14.58+0.4%$16.95+16.3%-9.5%$12.17B$325.54B22.0827,811News CoverageEarnings ReportUpcoming EarningsVTRSViatris2.4607 of 5 stars$9.14+0.2%$10.40+13.8%-18.5%$10.73B$14.74B-2.8832,000 Related Companies and Tools Related Companies ONC Alternatives BNTX Alternatives INSM Alternatives SMMT Alternatives TEVA Alternatives ITCI Alternatives GMAB Alternatives MRNA Alternatives RDY Alternatives VTRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RVMD) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
